

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mannosylation (GO:0097502) | 6.11341555 |
| 2 | rRNA catabolic process (GO:0016075) | 5.71655287 |
| 3 | ether lipid metabolic process (GO:0046485) | 4.76818857 |
| 4 | autophagic vacuole fusion (GO:0000046) | 4.40762887 |
| 5 | response to lipoprotein particle (GO:0055094) | 4.27650435 |
| 6 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.04967492 |
| 7 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.04967492 |
| 8 | NADH dehydrogenase complex assembly (GO:0010257) | 4.04967492 |
| 9 | protein complex biogenesis (GO:0070271) | 4.04242841 |
| 10 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 4.00312672 |
| 11 | GPI anchor metabolic process (GO:0006505) | 3.95067652 |
| 12 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.86173488 |
| 13 | organelle membrane fusion (GO:0090174) | 3.84991345 |
| 14 | GPI anchor biosynthetic process (GO:0006506) | 3.80256742 |
| 15 | positive regulation of digestive system process (GO:0060456) | 3.77606854 |
| 16 | adenosine metabolic process (GO:0046085) | 3.76868614 |
| 17 | response to pheromone (GO:0019236) | 3.71481142 |
| 18 | amino-acid betaine transport (GO:0015838) | 3.62440979 |
| 19 | carnitine transport (GO:0015879) | 3.62440979 |
| 20 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.59863967 |
| 21 | carnitine transmembrane transport (GO:1902603) | 3.56321288 |
| 22 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.52802585 |
| 23 | positive regulation of prostaglandin secretion (GO:0032308) | 3.49527074 |
| 24 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.40614372 |
| 25 | glycerol ether metabolic process (GO:0006662) | 3.28753791 |
| 26 | regulation of hexokinase activity (GO:1903299) | 3.27527545 |
| 27 | regulation of glucokinase activity (GO:0033131) | 3.27527545 |
| 28 | respiratory chain complex IV assembly (GO:0008535) | 3.26038285 |
| 29 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.21330229 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 3.15006007 |
| 31 | cytochrome complex assembly (GO:0017004) | 3.12184095 |
| 32 | labyrinthine layer development (GO:0060711) | 3.09451305 |
| 33 | DNA double-strand break processing (GO:0000729) | 3.09400310 |
| 34 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.06018147 |
| 35 | regulation of growth of symbiont in host (GO:0044126) | 3.06018147 |
| 36 | negative regulation of growth of symbiont in host (GO:0044130) | 3.06018147 |
| 37 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.06018147 |
| 38 | ether metabolic process (GO:0018904) | 3.05067424 |
| 39 | axoneme assembly (GO:0035082) | 2.94905528 |
| 40 | cellular response to antibiotic (GO:0071236) | 2.94331027 |
| 41 | xenobiotic catabolic process (GO:0042178) | 2.87158643 |
| 42 | protein polyglutamylation (GO:0018095) | 2.85723388 |
| 43 | C-terminal protein lipidation (GO:0006501) | 2.85027320 |
| 44 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.84902453 |
| 45 | quaternary ammonium group transport (GO:0015697) | 2.84740619 |
| 46 | phenylpropanoid metabolic process (GO:0009698) | 2.83286704 |
| 47 | glyoxylate metabolic process (GO:0046487) | 2.82865049 |
| 48 | ketone body metabolic process (GO:1902224) | 2.81972217 |
| 49 | urate metabolic process (GO:0046415) | 2.80841716 |
| 50 | organic cation transport (GO:0015695) | 2.79524880 |
| 51 | proteasome assembly (GO:0043248) | 2.77603067 |
| 52 | response to nitrosative stress (GO:0051409) | 2.76184449 |
| 53 | cellular response to interferon-beta (GO:0035458) | 2.74940004 |
| 54 | branched-chain amino acid catabolic process (GO:0009083) | 2.73696591 |
| 55 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.68951491 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 2.67562985 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 2.67562985 |
| 58 | tryptophan catabolic process (GO:0006569) | 2.67562985 |
| 59 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.66692359 |
| 60 | maturation of 5.8S rRNA (GO:0000460) | 2.65592320 |
| 61 | nucleobase catabolic process (GO:0046113) | 2.64193749 |
| 62 | RNA phosphodiester bond hydrolysis (GO:0090501) | 2.63276981 |
| 63 | lactate metabolic process (GO:0006089) | 2.61699666 |
| 64 | amino acid salvage (GO:0043102) | 2.61662362 |
| 65 | L-methionine salvage (GO:0071267) | 2.61662362 |
| 66 | L-methionine biosynthetic process (GO:0071265) | 2.61662362 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.61414081 |
| 68 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.60344724 |
| 69 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.59869320 |
| 70 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.59140141 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 2.59001058 |
| 72 | peroxisome organization (GO:0007031) | 2.58488161 |
| 73 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.57807928 |
| 74 | deoxyribonucleotide catabolic process (GO:0009264) | 2.57632326 |
| 75 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.56983030 |
| 76 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.56983030 |
| 77 | acrosome assembly (GO:0001675) | 2.56330938 |
| 78 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.53671785 |
| 79 | positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) | 2.52865718 |
| 80 | ncRNA catabolic process (GO:0034661) | 2.52160195 |
| 81 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.51968144 |
| 82 | regulation of prostaglandin secretion (GO:0032306) | 2.51837006 |
| 83 | protein import into peroxisome matrix (GO:0016558) | 2.51782226 |
| 84 | positive regulation of fatty acid transport (GO:2000193) | 2.51088914 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 2.49601512 |
| 86 | amine catabolic process (GO:0009310) | 2.49601512 |
| 87 | DNA methylation involved in gamete generation (GO:0043046) | 2.49162712 |
| 88 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.48885668 |
| 89 | S-adenosylmethionine metabolic process (GO:0046500) | 2.48865279 |
| 90 | C-terminal protein amino acid modification (GO:0018410) | 2.48331826 |
| 91 | deoxyribose phosphate catabolic process (GO:0046386) | 2.47262213 |
| 92 | purine-containing compound salvage (GO:0043101) | 2.46401610 |
| 93 | positive regulation of icosanoid secretion (GO:0032305) | 2.44600465 |
| 94 | angiotensin maturation (GO:0002003) | 2.43040497 |
| 95 | regulation of triglyceride catabolic process (GO:0010896) | 2.42595782 |
| 96 | response to interferon-beta (GO:0035456) | 2.42081403 |
| 97 | positive regulation of mRNA catabolic process (GO:0061014) | 2.41694618 |
| 98 | positive regulation of calcium ion import (GO:0090280) | 2.41363603 |
| 99 | positive regulation of respiratory burst (GO:0060267) | 2.41237202 |
| 100 | cellular response to toxic substance (GO:0097237) | 2.40594737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.53577859 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.03836877 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.51999190 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.38022150 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.00316340 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.85608201 |
| 7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.81479884 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.81076712 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.76332412 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.74296804 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.59956920 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.47833015 |
| 13 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.38816484 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35218655 |
| 15 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.32682673 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29556162 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24200712 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.23059605 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09354196 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 2.05821745 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90967221 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89817719 |
| 23 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.88874655 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.86473256 |
| 25 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.82812909 |
| 26 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.82812909 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.81159335 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.79438663 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.79417454 |
| 30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.73705555 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.73128844 |
| 32 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.71031131 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66981669 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66238185 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.58581279 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49768172 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.48777218 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46827968 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46631491 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.42285478 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.40399872 |
| 42 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.40393171 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39784324 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38975299 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38930339 |
| 46 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.35916517 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33720345 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.33071856 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32772778 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29020109 |
| 51 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26715344 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25480228 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24053333 |
| 54 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.20852324 |
| 55 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.20504010 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20399468 |
| 57 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.20374579 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17362417 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15978283 |
| 60 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.13715313 |
| 61 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.13064225 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10619309 |
| 63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10619309 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10171060 |
| 65 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08015048 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06833838 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.06297408 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04572198 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04563398 |
| 70 | NCOR_22424771_ChIP-Seq_293T_Human | 1.04270532 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.02804178 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01751386 |
| 73 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01205665 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00350918 |
| 75 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98672039 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98484276 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 0.97856421 |
| 78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96796463 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96624132 |
| 80 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95122755 |
| 81 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95122755 |
| 82 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94078611 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 0.93790487 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92869102 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.92235915 |
| 86 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91147067 |
| 87 | CBP_21632823_ChIP-Seq_H3396_Human | 0.90927089 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89380130 |
| 89 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.88139451 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88079987 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88058946 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87323484 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86386242 |
| 94 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86286441 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86229834 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.85687530 |
| 97 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84569241 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 0.83607772 |
| 99 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82079227 |
| 100 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.81761993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 6.59809432 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.36765924 |
| 3 | MP0001986_abnormal_taste_sensitivity | 3.33296918 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.18274024 |
| 5 | MP0000372_irregular_coat_pigmentation | 3.04835473 |
| 6 | MP0004043_abnormal_pH_regulation | 2.68587198 |
| 7 | MP0005083_abnormal_biliary_tract | 2.21806411 |
| 8 | MP0005646_abnormal_pituitary_gland | 2.18798243 |
| 9 | MP0003787_abnormal_imprinting | 2.18520613 |
| 10 | MP0001764_abnormal_homeostasis | 2.10014628 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 1.94827545 |
| 12 | MP0005451_abnormal_body_composition | 1.89337624 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87286676 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 1.86787891 |
| 15 | MP0001545_abnormal_hematopoietic_system | 1.86787891 |
| 16 | MP0003724_increased_susceptibility_to | 1.81457061 |
| 17 | MP0002163_abnormal_gland_morphology | 1.77757778 |
| 18 | MP0002132_abnormal_respiratory_system | 1.75768081 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 1.71592411 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.70526802 |
| 21 | MP0004484_altered_response_of | 1.70264129 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.67707168 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.66971755 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.62818053 |
| 25 | MP0008058_abnormal_DNA_repair | 1.61268451 |
| 26 | MP0003646_muscle_fatigue | 1.60052455 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.57534873 |
| 28 | MP0005367_renal/urinary_system_phenotyp | 1.54027046 |
| 29 | MP0000516_abnormal_urinary_system | 1.54027046 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.51185254 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.51098687 |
| 32 | MP0004147_increased_porphyrin_level | 1.49038251 |
| 33 | MP0003718_maternal_effect | 1.47977621 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.44947296 |
| 35 | MP0005671_abnormal_response_to | 1.43477575 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.41561693 |
| 37 | MP0004142_abnormal_muscle_tone | 1.40132830 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.39832517 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.38156460 |
| 40 | MP0008995_early_reproductive_senescence | 1.34516220 |
| 41 | MP0009278_abnormal_bone_marrow | 1.32856774 |
| 42 | MP0005379_endocrine/exocrine_gland_phen | 1.31516414 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.28984442 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.22257911 |
| 45 | MP0002160_abnormal_reproductive_system | 1.21054228 |
| 46 | MP0000639_abnormal_adrenal_gland | 1.18964834 |
| 47 | MP0009046_muscle_twitch | 1.18956278 |
| 48 | MP0005410_abnormal_fertilization | 1.16743271 |
| 49 | MP0005332_abnormal_amino_acid | 1.15556130 |
| 50 | MP0005365_abnormal_bile_salt | 1.13079671 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.10636681 |
| 52 | MP0003786_premature_aging | 1.08783634 |
| 53 | MP0004134_abnormal_chest_morphology | 1.08756694 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.08244575 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 1.07780292 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.05149372 |
| 57 | MP0005165_increased_susceptibility_to | 0.97489983 |
| 58 | MP0003123_paternal_imprinting | 0.97317299 |
| 59 | MP0002693_abnormal_pancreas_physiology | 0.96566133 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.94146086 |
| 61 | MP0003075_altered_response_to | 0.91028573 |
| 62 | MP0005389_reproductive_system_phenotype | 0.88460688 |
| 63 | MP0005376_homeostasis/metabolism_phenot | 0.88011407 |
| 64 | MP0005670_abnormal_white_adipose | 0.87165586 |
| 65 | MP0005330_cardiomyopathy | 0.83829569 |
| 66 | MP0005408_hypopigmentation | 0.81462706 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.80024776 |
| 68 | MP0008872_abnormal_physiological_respon | 0.79996223 |
| 69 | MP0005000_abnormal_immune_tolerance | 0.79523499 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.79119239 |
| 71 | MP0001968_abnormal_touch/_nociception | 0.78916885 |
| 72 | MP0005266_abnormal_metabolism | 0.77965240 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 0.75933288 |
| 74 | MP0001661_extended_life_span | 0.72717945 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 0.72578910 |
| 76 | MP0000569_abnormal_digit_pigmentation | 0.72514249 |
| 77 | MP0009785_altered_susceptibility_to | 0.72193610 |
| 78 | MP0008873_increased_physiological_sensi | 0.70931123 |
| 79 | MP0005395_other_phenotype | 0.69978718 |
| 80 | MP0000689_abnormal_spleen_morphology | 0.69773521 |
| 81 | MP0002419_abnormal_innate_immunity | 0.68557935 |
| 82 | MP0001873_stomach_inflammation | 0.68366347 |
| 83 | MP0009697_abnormal_copulation | 0.68151496 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.68013336 |
| 85 | MP0008004_abnormal_stomach_pH | 0.66748876 |
| 86 | MP0003698_abnormal_male_reproductive | 0.66020856 |
| 87 | MP0005025_abnormal_response_to | 0.65063448 |
| 88 | MP0005360_urolithiasis | 0.64903844 |
| 89 | MP0002420_abnormal_adaptive_immunity | 0.64291335 |
| 90 | MP0002234_abnormal_pharynx_morphology | 0.63812203 |
| 91 | MP0001324_abnormal_eye_pigmentation | 0.63510410 |
| 92 | MP0001819_abnormal_immune_cell | 0.63072222 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.62812080 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.62631907 |
| 95 | MP0003252_abnormal_bile_duct | 0.62026919 |
| 96 | MP0002095_abnormal_skin_pigmentation | 0.62016331 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.61879159 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 0.61711718 |
| 99 | MP0003121_genomic_imprinting | 0.61185603 |
| 100 | MP0001919_abnormal_reproductive_system | 0.60449690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tongue fasciculations (HP:0001308) | 4.58093706 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.40082804 |
| 3 | Muscle fibrillation (HP:0010546) | 3.83022716 |
| 4 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.82268059 |
| 5 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.82268059 |
| 6 | Abnormal protein glycosylation (HP:0012346) | 3.82268059 |
| 7 | Abnormal glycosylation (HP:0012345) | 3.82268059 |
| 8 | Type I transferrin isoform profile (HP:0003642) | 3.54073126 |
| 9 | Increased circulating renin level (HP:0000848) | 3.50261752 |
| 10 | Hypomagnesemia (HP:0002917) | 3.36494768 |
| 11 | Failure to thrive in infancy (HP:0001531) | 3.15377214 |
| 12 | Abnormal drinking behavior (HP:0030082) | 3.06777147 |
| 13 | Polydipsia (HP:0001959) | 3.06777147 |
| 14 | Pancreatic fibrosis (HP:0100732) | 2.99865823 |
| 15 | Ketoacidosis (HP:0001993) | 2.82915403 |
| 16 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.79784175 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 2.76355453 |
| 18 | True hermaphroditism (HP:0010459) | 2.68894737 |
| 19 | Tetany (HP:0001281) | 2.65470595 |
| 20 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.61309917 |
| 21 | Reduced antithrombin III activity (HP:0001976) | 2.58700052 |
| 22 | Acute encephalopathy (HP:0006846) | 2.58468071 |
| 23 | Acute necrotizing encephalopathy (HP:0006965) | 2.56978548 |
| 24 | Nephronophthisis (HP:0000090) | 2.56559304 |
| 25 | Mitochondrial inheritance (HP:0001427) | 2.54836780 |
| 26 | Abnormality of magnesium homeostasis (HP:0004921) | 2.53500417 |
| 27 | Ketosis (HP:0001946) | 2.51154885 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 2.50818175 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 2.50818175 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.50724412 |
| 31 | Congenital stationary night blindness (HP:0007642) | 2.48648079 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.46069356 |
| 33 | Type 2 muscle fiber atrophy (HP:0003554) | 2.43174276 |
| 34 | Hepatic necrosis (HP:0002605) | 2.41831319 |
| 35 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.40133816 |
| 36 | Short 1st metacarpal (HP:0010034) | 2.40133816 |
| 37 | Abnormality of the prostate (HP:0008775) | 2.39325080 |
| 38 | Pancreatic cysts (HP:0001737) | 2.38316201 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.32650611 |
| 40 | Severe visual impairment (HP:0001141) | 2.32587880 |
| 41 | Metaphyseal dysplasia (HP:0100255) | 2.32168973 |
| 42 | Hyperphosphatemia (HP:0002905) | 2.30893240 |
| 43 | Cerebral edema (HP:0002181) | 2.29050521 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.27119925 |
| 45 | Lipid accumulation in hepatocytes (HP:0006561) | 2.24251278 |
| 46 | Increased CSF lactate (HP:0002490) | 2.23431514 |
| 47 | Hyperammonemia (HP:0001987) | 2.22216638 |
| 48 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.20602500 |
| 49 | Hepatocellular necrosis (HP:0001404) | 2.20083260 |
| 50 | Lethargy (HP:0001254) | 2.19182398 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.16369648 |
| 52 | Abnormality of the 1st metacarpal (HP:0010009) | 2.13100649 |
| 53 | Hypothermia (HP:0002045) | 2.08995431 |
| 54 | Short tibia (HP:0005736) | 2.08400470 |
| 55 | Polyuria (HP:0000103) | 2.05993429 |
| 56 | Abnormality of lateral ventricle (HP:0030047) | 2.04483266 |
| 57 | Increased serum pyruvate (HP:0003542) | 2.04169797 |
| 58 | Muscle fiber atrophy (HP:0100295) | 2.03043897 |
| 59 | Dry hair (HP:0011359) | 2.02792658 |
| 60 | Attenuation of retinal blood vessels (HP:0007843) | 2.02378278 |
| 61 | Exertional dyspnea (HP:0002875) | 2.02044860 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.00849512 |
| 63 | Glycosuria (HP:0003076) | 2.00849512 |
| 64 | Confusion (HP:0001289) | 1.99736640 |
| 65 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.99192809 |
| 66 | Prolonged partial thromboplastin time (HP:0003645) | 1.99127426 |
| 67 | Epidermoid cyst (HP:0200040) | 1.98902364 |
| 68 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98838503 |
| 69 | Hyperglycinemia (HP:0002154) | 1.98422843 |
| 70 | Hyperphosphaturia (HP:0003109) | 1.97566140 |
| 71 | Increased hepatocellular lipid droplets (HP:0006565) | 1.95594949 |
| 72 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.95308949 |
| 73 | Abnormality of the renal medulla (HP:0100957) | 1.93108167 |
| 74 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.92200544 |
| 75 | Renal Fanconi syndrome (HP:0001994) | 1.91953205 |
| 76 | Stomatitis (HP:0010280) | 1.90764636 |
| 77 | Lower limb hyperreflexia (HP:0002395) | 1.86550547 |
| 78 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.86142816 |
| 79 | Chronic hepatic failure (HP:0100626) | 1.83283505 |
| 80 | Increased muscle lipid content (HP:0009058) | 1.83118360 |
| 81 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82984933 |
| 82 | Congenital hepatic fibrosis (HP:0002612) | 1.82156211 |
| 83 | Limb ataxia (HP:0002070) | 1.81105636 |
| 84 | Abnormal urine output (HP:0012590) | 1.80874905 |
| 85 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79957174 |
| 86 | Hypoplasia of the uterus (HP:0000013) | 1.79016222 |
| 87 | Type I diabetes mellitus (HP:0100651) | 1.78881826 |
| 88 | Constricted visual fields (HP:0001133) | 1.77727855 |
| 89 | Abnormality of the metopic suture (HP:0005556) | 1.77368764 |
| 90 | Aplastic anemia (HP:0001915) | 1.76986911 |
| 91 | Abnormality of renin-angiotensin system (HP:0000847) | 1.76427397 |
| 92 | Optic disc pallor (HP:0000543) | 1.72613589 |
| 93 | Late onset (HP:0003584) | 1.72589783 |
| 94 | Abnormality of glycolysis (HP:0004366) | 1.72259211 |
| 95 | Metabolic acidosis (HP:0001942) | 1.71878146 |
| 96 | Opisthotonus (HP:0002179) | 1.71729038 |
| 97 | Anhidrosis (HP:0000970) | 1.71531226 |
| 98 | Focal motor seizures (HP:0011153) | 1.71485132 |
| 99 | Disproportionate short-trunk short stature (HP:0003521) | 1.70699476 |
| 100 | Intestinal atresia (HP:0011100) | 1.69684696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 7.26081244 |
| 2 | FRK | 3.81729501 |
| 3 | BCKDK | 2.69091853 |
| 4 | MKNK1 | 2.66306497 |
| 5 | TNK2 | 2.59513861 |
| 6 | NME2 | 2.29509077 |
| 7 | SCYL2 | 2.26726257 |
| 8 | ZAK | 2.25401667 |
| 9 | MAPKAPK5 | 2.18626747 |
| 10 | TAOK3 | 2.17644895 |
| 11 | EIF2AK3 | 2.10811989 |
| 12 | FLT3 | 2.04893674 |
| 13 | CLK1 | 1.79610698 |
| 14 | PKN2 | 1.76934371 |
| 15 | PBK | 1.73680226 |
| 16 | PLK2 | 1.73246992 |
| 17 | EIF2AK1 | 1.65932067 |
| 18 | GRK1 | 1.57831878 |
| 19 | TEC | 1.57074240 |
| 20 | TLK1 | 1.55312491 |
| 21 | MAP2K3 | 1.45954563 |
| 22 | BLK | 1.40464844 |
| 23 | RPS6KA5 | 1.39925842 |
| 24 | ADRBK2 | 1.32561484 |
| 25 | ITK | 1.31474550 |
| 26 | MAP3K3 | 1.31443147 |
| 27 | BMPR1B | 1.27049195 |
| 28 | MAP3K6 | 1.20284100 |
| 29 | PIM2 | 1.17901207 |
| 30 | CDK8 | 1.13635930 |
| 31 | TXK | 1.10181737 |
| 32 | MAP3K10 | 1.09199732 |
| 33 | PRKCI | 1.06763675 |
| 34 | VRK1 | 1.04252593 |
| 35 | PAK3 | 1.01919340 |
| 36 | MAP2K6 | 1.01416774 |
| 37 | MST4 | 0.97014073 |
| 38 | PHKG2 | 0.95174329 |
| 39 | PHKG1 | 0.95174329 |
| 40 | MAP3K5 | 0.92089246 |
| 41 | TRIM28 | 0.91740987 |
| 42 | ARAF | 0.90696661 |
| 43 | OXSR1 | 0.90471382 |
| 44 | TBK1 | 0.89147990 |
| 45 | IKBKE | 0.84825966 |
| 46 | VRK2 | 0.84023593 |
| 47 | DAPK2 | 0.84017229 |
| 48 | FES | 0.83540033 |
| 49 | FER | 0.82806627 |
| 50 | PIK3CG | 0.82119259 |
| 51 | BTK | 0.81986252 |
| 52 | SYK | 0.80741218 |
| 53 | MAP3K12 | 0.77833180 |
| 54 | INSRR | 0.76542186 |
| 55 | IKBKB | 0.75090017 |
| 56 | MAP4K1 | 0.72173494 |
| 57 | PLK4 | 0.71804707 |
| 58 | PDK2 | 0.70607320 |
| 59 | KIT | 0.70170557 |
| 60 | LYN | 0.69574439 |
| 61 | ADRBK1 | 0.64922819 |
| 62 | FGFR2 | 0.63221292 |
| 63 | PRKCQ | 0.60797487 |
| 64 | MAP3K11 | 0.60362565 |
| 65 | PRKCE | 0.59128303 |
| 66 | ZAP70 | 0.58693747 |
| 67 | MAP2K4 | 0.58193064 |
| 68 | RPS6KA4 | 0.57035424 |
| 69 | CDK3 | 0.55679838 |
| 70 | STK16 | 0.55617790 |
| 71 | MARK1 | 0.52991464 |
| 72 | PRKCG | 0.51017924 |
| 73 | NEK1 | 0.50455925 |
| 74 | NUAK1 | 0.50292691 |
| 75 | ABL1 | 0.49541840 |
| 76 | ABL2 | 0.45142297 |
| 77 | MAPK11 | 0.44367243 |
| 78 | TGFBR1 | 0.43957193 |
| 79 | STK38 | 0.43117467 |
| 80 | PASK | 0.42490099 |
| 81 | TAF1 | 0.41578337 |
| 82 | CDK6 | 0.41353522 |
| 83 | TAOK1 | 0.38660818 |
| 84 | DAPK1 | 0.38000103 |
| 85 | NEK6 | 0.37969753 |
| 86 | MAP2K7 | 0.37688747 |
| 87 | IRAK3 | 0.37666806 |
| 88 | PRKACA | 0.36640513 |
| 89 | SGK3 | 0.36486229 |
| 90 | MAPK13 | 0.34234320 |
| 91 | TIE1 | 0.33115119 |
| 92 | BMPR2 | 0.32908277 |
| 93 | FGFR3 | 0.32673635 |
| 94 | PRKCB | 0.32309359 |
| 95 | HCK | 0.31827336 |
| 96 | KDR | 0.31737912 |
| 97 | ICK | 0.31108683 |
| 98 | YES1 | 0.29448022 |
| 99 | SGK2 | 0.28803308 |
| 100 | PRKAA1 | 0.28670999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.78943919 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.53674679 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.40390686 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.33072155 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.26261969 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18566949 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.18197929 |
| 8 | * Peroxisome_Homo sapiens_hsa04146 | 2.17667083 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.16638096 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.11447427 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.09782092 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08108530 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.07046308 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.06249228 |
| 15 | * Retinol metabolism_Homo sapiens_hsa00830 | 2.05604722 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.95095065 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94564241 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.88835223 |
| 19 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.81502708 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76244422 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.76199504 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.71649035 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70551690 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.67728241 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66509443 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61122964 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53641597 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.51025013 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.48003350 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44025433 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.39314191 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34589330 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.33038477 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31367662 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27640541 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.27502712 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25949492 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.24795887 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22466179 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.20148182 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.19883351 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19586901 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16556416 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15776122 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.07123442 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06775089 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04786522 |
| 48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.01547717 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98274773 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97846979 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95677164 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94207981 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93380354 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.89057912 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88682459 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.88018137 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87215804 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86896885 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 0.86755256 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86261176 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84765560 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.83924832 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.81280079 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81096153 |
| 65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.80036141 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76975023 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76463176 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73910230 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73874026 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73438190 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.70993098 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70310210 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70304576 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65954505 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62304419 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61977792 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61730351 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61436438 |
| 79 | RNA transport_Homo sapiens_hsa03013 | 0.60565492 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60281502 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60207825 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58617053 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57283431 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55079384 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54081694 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50885034 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50662243 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49563970 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45411330 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44588664 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.42454392 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41215885 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39781107 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39691989 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.39551922 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37892131 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35471222 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.33481008 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30059141 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.28704901 |

